Key result
Specialized women's heart centers improve ASCVD management through sex-specific diagnostics and guideline-directed therapies.
Why the study?
Sex differences manifest in how ASCVD progresses, requiring recognition of clinical differences and social disparities to effectively prevent morbidity and cardiovascular death in women.
Heart centers for women are essential for implementing sex-specific, guideline-directed therapies and addressing social determinants of health to prevent and manage ASCVD in women.
Supports integration of sex-specific ASCVD strategies via women's heart centers; leaves open outcome impact without prospective trials.
There are sex differences in how atherosclerotic cardiovascular disease (ASCVD) manifests and progresses. Appropriate management requires not only recognition of sex-based clinical differences but in the social disparities may influence outcomes. The establishment of heart centers for women emerged as a response to the escalating deaths in women from cardiovascular disease from 1984 to 2000. Since then, studies have provided further insights into sex differences in ASCVD management. Preventing ASCVD remains crucial in reducing morbidity and death from cardiovascular events in women. Heart centers for women play a crucial role in managing ASCVD in women, with health care professionals at the forefront of this effort. This article summarizes the most current guideline-supported therapies and diagnostic tools essential for preventing and treating ASCVD in women. It also emphasizes the critical importance of acknowledging social determinants of health, fostering empathy and understanding among health care professionals, and asserts that increasing women's participation in cardiovascular trials is vital for advancing research and improving outcomes.
No takes yet. Share an insight, caveat, or question.
Jonas et al. (2026) conducted a review in Atherosclerotic Cardiovascular Disease (ASCVD) in Women. Heart centers for women and sex-specific ASCVD management was evaluated. Heart centers for women play a crucial role in managing ASCVD by implementing sex-specific diagnostic tools and guideline-directed medical therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: